BAY-218, also known as BAY-2335218, is a potent and selective small-molecule AhR inhibitor, as a new modality to counteract tumor immunosuppression.
For research use only. We do not sell to patients.
Name | BAY-218 |
---|---|
Iupac Chemical Name | (S)-6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide |
Synonyms | BAY-218; BAY 218; BAY218; BAY-2335218; BAY 2335218; BAY2335218; |
Molecular Formula | C20H17ClFN3O3 |
Molecular Weight | 401.8224 |
InChiKey | RFGRNBWAUZSMBN-LBPRGKRZSA-N |
InChi | InChI=1S/C20H17ClFN3O3/c1-12(11-26)23-19(27)17-10-18(13-5-7-14(21)8-6-13)24-25(20(17)28)16-4-2-3-15(22)9-16/h2-10,12,26H,11H2,1H3,(H,23,27)/t12-/m0/s1 |
CAS Number | 2162982-11-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |